2019
-
09
-
06
点击次数:
Skyran Biologics has a group of compounds that treat many of the major eye diseasesThese compounds are at different stages of development – with some ready for manufactureThe market for these compounds is huge – and growingWith appropriate investment Skyran Biologics will be generating revenue in 1-2 yearsWith new drugs coming on line we expect continuing robust revenue growth.